Emanuele Marra

Title: Emanuele Marra: Innovator in Cancer Immunotherapy

Introduction

Emanuele Marra is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a focus on immunotherapy, Marra's work aims to improve the lives of patients suffering from cancer.

Latest Patents

Emanuele Marra holds 2 patents related to immunotherapy against the ErbB-3 receptor. His inventions describe methods and pharmaceutical compositions for the treatment of cancer in mammals, particularly in human subjects. Specifically, these patents concern anti-tumor vaccines based on plasmid DNA and/or genetic vectors that carry a codon-usage optimized sequence coding for a mutant form of the ErbB-3 receptor. Furthermore, the inventions refer to monoclonal antibodies directed against the ErbB-3 receptor, which are obtained using these methods and are capable of blocking its activity in cancer cells.

Career Highlights

Emanuele Marra is currently associated with Takis S.r.l., a company dedicated to advancing cancer therapies. His work at Takis S.r.l. has positioned him as a key player in the field of immunotherapy, contributing to the development of innovative treatments that target specific cancer receptors.

Collaborations

Marra collaborates with esteemed colleagues such as Luigi Aurisicchio and Gennaro Ciliberto. These partnerships enhance the research and development efforts at Takis S.r.l., fostering an environment of innovation and scientific advancement.

Conclusion

Emanuele Marra's contributions to cancer immunotherapy through his patents and collaborations highlight his commitment to improving treatment options for patients. His work continues to pave the way for advancements in the field of oncology.